FIELD: medicine.
SUBSTANCE: method involves administering Corbiculin at a dose of 2 g three times a day when prediluted with 50 ml of water. The treatment course is 21 days long or longer until alanine aminotransferase and aspartate aminotransferase indices assume normal values.
EFFECT: enhanced effectiveness in normalizing hyperenzymemia and relieving clinic manifestations of cytolytic syndrome.
2 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT "EXTRAHOLM" FOR SUGAR CONTROL IN PATIENTS SUFFERING FROM DIABETES COMPLICATED BY HEPATOPATHY AND BILE PASSAGES DISORDERS | 2007 |
|
RU2360695C1 |
METHOD OF COMPLEX TREATMENT OF CHRONIC VIRAL HEPATITISIS TYPES B AND C | 2007 |
|
RU2341275C1 |
METHOD OF TREATMENT OF LIVER DISEASES | 2006 |
|
RU2334499C2 |
METHOD FOR SELECTION OF MEDICINAL PREPARATIONS FOR TREATMENT OF PATIENTS WITH CHRONIC VIRAL HEPATITIS C | 2002 |
|
RU2221243C1 |
MEDICATION FOR TREATMENT OF PATIENTS WITH DRUG HEPATITIS | 2009 |
|
RU2419449C1 |
METHOD OF TREATING PATIENTS WITH HEPATIC CIRRHOSIS | 2012 |
|
RU2509566C1 |
METHOD FOR TREATMENT OF CHRONIC HEPATITIS | 2005 |
|
RU2286792C1 |
METHOD OF TREATING NON-ALCOHOLIC STEATOHEPATITIS WITH APPLICATION OF DALARGIN MAGNETOPHORESIS | 2011 |
|
RU2473325C1 |
METHOD OF PREVENTION OF CHRONIC VIRAL HEPATITIS TYPE C RECURRENT AFTER VIRUS REMISSION | 2007 |
|
RU2348412C1 |
METHOD OF TREATING PATIENTS SUFFERING FROM FIRST STAGE CHOLELITHIASIS | 2012 |
|
RU2519198C2 |
Authors
Dates
2006-05-10—Published
2004-05-19—Filed